$AIZ Cashflow Statement | Understand Stock

$AIZ

$286.30 -$0.85 (0.3%) Close

$AIZ Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Noncash revenues, expenses, gains and losses included in income:
(Income) loss from discontinued operations
Deferred tax expense (benefit)
Depreciation and amortization
Net realized losses on investments, including impairment losses
Loss (gain) on extinguishment of debt
Restructuring costs
Loss on sale of business
Stock based compensation expense
Other intangible asset impairment
Goodwill impairment
Iké related charges, net of derivative gains

Changes in operating assets and liabilities:
Insurance policy reserves and expenses
Premiums and accounts receivable
Commissions payable
Reinsurance recoverable
Reinsurance balance payable
Funds withheld under reinsurance
Deferred acquisition costs and value of business acquired (Note 12 and 15)
Taxes receivable
Other assets and other liabilities
Other
Net cash provided by operating activities - discontinued operations
Net cash provided by operating activities
Investing activities
Sales of:
Fixed maturity securities available for sale
Equity securities
Other invested assets
Subsidiary, net of cash transferred
Iké foreign currency hedge

Maturities, calls, prepayments, and scheduled redemption of:
Fixed maturity securities available for sale
Commercial mortgage loans on real estate
Purchases of:
Fixed maturity securities available for sale
Equity securities
Commercial mortgage loans on real estate
Other invested assets
Property and equipment and other
Subsidiary, net of cash transferred
Net cash outflow related to sale of interests in Iké and termination of put/call obligations
Purchases of investments
Sale of investments

Change in short-term investments
Other
Net cash used in investing activities - discontinued operations
Net cash used in investing activities
Financing activities
Issuance of debt, net of issuance costs (Note 18)
Issuance of collateralized loan obligation notes
Issuance of debt for consolidated investment entities
Repayment of debt for consolidated investment entities
Borrowing under unsecured revolving credit facility
Payments on unsecured revolving credit facility
Repayment of debt
Payment of contingent liability
Acquisition of common stock
Common stock dividends paid
Preferred stock dividends paid
Proceeds from transfer of rights to ACA recoverables (Note 4)
Proceeds repaid on transfer of rights to ACA recoverable (Note 4)
Other
Net cash (used in) provided by financing activities - discontinued operations
Employee stock purchases and withholdings
Net cash used in financing activities

Effect of exchange rate changes on cash and cash equivalents - continuing operations
Effect of exchange rate changes on cash and cash equivalents - discontinued operations
Effect of exchange rate changes on cash and cash equivalents
Change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Less: Cash and cash equivalents reclassified as held for sale at end of period
Less: Cash and cash equivalents of discontinued operations at end of period
Income taxes paid
Interest paid on debt
Cash and cash equivalents at beginning of period - continuing operations
Cash and cash equivalents of continuing operations at end of period

Comments